Dear Colleague,

Come join us in beautiful Washington DC o­n the 3rd & 4th as we release groundbreaking information o­n vaccines.

"Vaccines - All Things Considered" will explore new approaches and technologies to this imperative issue in society. This conference will cover many important aspects of vaccine discovery, development, acceptance and alternatives. Reports and successful stories of smallpox and polio, why concerns about an influenza outbreak remain fervent, and the progress of potential technologies, are just a few of the many topics to be discussed. This meeting is a keystone in the building blocks of interactive networks between developed and developing countries from all aspects.

Topics and Sessions Include:

• Vaccine Policy and Legislation (Product Liability, FDA regulations, Stockpile, Bioshield)

• Scientific Advances of Vaccines (Diabetes, RSV, HPV, Autoimmune, Influenza, MPA, Oral Delivery, Transdermal Options and Nasal Mist Options)

• Vaccines needs and vaccines in 3rd world countries

• Planning Process for Vaccines

• Funding Opportunities from Public and Private Sources

• Vaccines in the Biotech and Pharmaceutical Industries

Please bring notice of this meeting to any colleagues that may benefit from attending. Please register early and submit an abstract.

Early registration: Register by Oct 3, 2005 to save 10%.

Abstracts deadline: Oct 3, 2005. A few abstracts will be selected for oral presentation.
 

Upcoming Events:

Therapeutic Strategies against Neurodegenerative Conditions
October 10 & 11, 2005 - Boston Marriott Burlington, Burlington, MA

RNA Research & Therapeutics
December 1 & 2, 2005 - The Dana o­n Mission Bay, San Diego, CA

3rd Anti-Infectives Partnering and Dealmaking Summit
Jan 26-27, 2006
San Diego, CA

4th Cytokines and Inflammation
Jan 30-31, 2006
San Diego, CA

KEYNOTE PRESENTATION:
"A Global Overview of the Movements and Progress of
Prophylactic and Therapeutic Vaccines"

Michel Klein, M.D., Executive Director, CANVAC, Université de Montréal